J’y effectue actuellement mon SIR et je dois dire que les formations de chirurgie robotique proposées sont de grande qualité : l’école dispose de matériel et de robots à la pointe de la technologie (Da Vinci notamment…). Elle est également le siège de nombreux projets de recherches tout aussi passionnants et innovants !
BREAKING NEWS ‼️ Intuitive have just announced that the da Vinci 5 has obtained CE mark. This will send shockwaves across the EU robotics market.
Why - because they got broad procedure acceptance - general surgery, pelvic surgery, Urology, GYN, and thoracic and more. Not just that they got the full power of the system - with the tower, the 10,000X compute, the Force feedback and the full goodies.
This is going to have a massive impact on surgical robotics in Europe - especially if they continue their pay per use models.
The power of the tower is now unleashed in Europe - and that means KARL STORZ Olympus Corporation Braun and all the tower manufacturers need to accelerate.
It also means added pressure to Johnson & Johnson and Medtronic as this system comes fully loaded with advanced energy and stapling. (Good to see Medtronic upgraded Hugo as well today with Ligasure and Rubina)
Surgical robotics in Europe is about to go to the next level !! Society of Robotic Surgery | SRS this year is going to be amazing to se all of this tech rolled out.
Curious about how robotics are changing the surgical field? This presentation will dive into the revolutionary da Vinci Surgical System and how it’s transforming surgical precision and patient outcomes.
Presented by: Karanthi Achanta, MD General Surgery
The research team at Icahn School of Medicine has published a very well written overview of robotic assist spine surgery complications. We have the “must-read” summary. Check it out.
Distalmotion’s Dexter Robotic Surgery System has received FDA 510(k) clearance for adult cholecystectomy, expanding its approved use in the U.S. as demand grows for outpatient robotic procedures.
Medial unicompartmental knee arthroplasty (MUKA) has become an established treatment option for medial compartment osteoarthritis. While advancements in materials and robotic-assisted surgery have improved outcomes, concerns about long-term survivorship persist. This systematic review and meta-analysis assess failure rates of MUKA based on implant design, follow-up periods, and surgical techniques.
Six systems for orthopaedic surgery have been given the green light by the National Institute for Health and Care Excellence (NICE) under its early value assessment programme, includes SkyWalker™, Mako and ROSA, etc.This is the first time that Chinese surgical robots have been recommended for use in the NHS.
SkyWalker™ has strong operability and adaptability, with a simple system installation process, smooth intraoperative operations, fast operation efficiency, reduced dependence on physician experience, decreased patient injuries, and accelerated patient recovery. Clinical data shows that the SkyWalker™'s accuracy in lower limb alignment, surgery time, blood loss, and postoperative knee joint clinical functional assessment are at an internationally leading level. SkyWalker™ assists in joint replacement surgeries by reducing the angle deviation of the replaced joint to within 0.5°, while also halving the surgery time and reducing blood loss by more than 30%.
SkyWalker™ has approved by NMPA、FDA、CE、TGA、ANVISA、MHRA、CDSCO、MHLW、CCPSA,and has been clinically applied in orthopedics, joint surgery, and sports medicine departments of 90 hospitals in more than 20 countries around the world, including China, the United States, Germany, Spain, and Brazil, assisting in the implementation of more than 2000 TKA surgeries.
“These innovative technologies can potentially transform orthopaedic surgical care in the NHS. The data gathered over the next three years will allow us to evaluate exactly how these technologies can improve patient care and help ensure NHS resources are directed toward interventions that deliver meaningful clinical benefits and long-term value to our health service,” commented Dr Anastasia Chalkidou, programme director of NICE’s HealthTech programme.
616 surgical robots designed by 550 medtech companies. 2/3 of these robots are in development, 14% only are commercial.
The rate of new devices & startups coming from China is slowing down. China did not pass the US as expected in 2024.
Cocorico. France remains the n°3 country after US & China.
The rate of endovascular startups has accelerated. China accounts for the majority of that.
Main areas that are targeted by robotics: 🔸Abdominal - thoracic 🔸Orthopedic 🔸Endovascular 🔸Spine 🔸Neuro 🔸GI - endoluminal 🔸Percutaneous 🔸Vascular access
And many other insights about where surgical robotics is today and where it's going in the latest update of 'Surgical Robotics Today' by Dwight Meglan.
A fantastic share with the community from an expert who's been working on no less than 15 commercial surgical robots.
The ortho robotics market is still a frontier and not yet a battlefield. This chart offers a rare peek into a space that, until now, has operated with more mystery than clarity.
With no centralized claims data and fragmented reporting, understanding market leadership in orthopedic robotics has felt more like speculation than science.
But this slide changes that—at least directionally (*Shout out to Brandon Wade and the team at Health Advances for this graphic.)
By comparing publicly stated procedure volumes, we begin to see a clearer landscape. Stryker’s Mako remains the dominant force.
Zimmer Biomet’s ROSA and Smith+Nephew’s NAVIO/CORI have earned meaningful traction.
And perhaps most notably, Globus Medical’s ExcelsiusGPS is gaining ground fast—thanks to the transparency they've offered by releasing growth data others won’t.
It’s important to say: this is not an exact market share breakdown.
It doesn’t reflect total penetration, nor does it consider the nuances of hospital system contracts or implant alignment. But it does signal momentum—and momentum attracts money, talent, and market share.
What stands out is how underpenetrated the market still is.
For all the noise, the ASC (ambulatory surgery center) space is just getting started. And that’s where the battle will be won or lost.
The key question: will adoption follow legacy implant lines, or will open systems and robotics-native platforms (like those from THINK Surgical, Monogram, or even J&J’s VELYS) reset the playing field?
This market feels like soft-tissue robotics in 2005.
Back then, Intuitive’s da Vinci wasn’t yet the 800-pound gorilla.
Today, it dominates.
The race is on.
And with the convergence of robotics, AI, and patient-specific implants, we may be closer to the tipping point than we think.
A great attempt and exploration, the combination of metaverse and robotic surgery technology, will bring unprecedented changes to the field of training, create a richer and more efficient learning environment for students, and promote the development of education towards a more equitable and personalized direction.
In the future, virtual surgical simulations in the metaverse will provide an excellent training platform for doctors. Through virtual reality technology, doctors can simulate various complex surgeries in a virtual environment, such as tumor resection surgery. In virtual surgery simulation, doctors can observe the surgical site from all angles and simulate various surgical situations, including normal operations and possible unexpected situations such as blood vessel rupture and organ adhesion. This immersive training method allows doctors to accumulate rich experience before actual surgery, improve surgical skills, and enhance their ability to respond to unexpected situations.
Congratulations,Dr Ahallal and the Oncorad Group teams.
The field of minimally invasive surgery has advanced significantly with the integration of laparoscopic and robotic techniques. Surgeons worldwide seek specialized training to master these cutting-edge technologies.
Not all robots are da Vinci 💥 Mendaera, Inc. is one of the growing specialised architectures of robotics that are getting smaller and smaller. And they just got FDA clearance this week. As part of a growing number of small form factors that use robotics for precision even when the "payload" delivery is the human arm. Like THINK Surgical, OBVIUS Robotics, Inc. and Microbot Medical - they are all smaller (and often even hand held.) versions of robotics. Different approaches to specialist applications.
For Mendaera - Focalist - their flagship product is a hand held navigation guided needle delivery device - it can be used for vascular access, Fine Needle Aspiration, and other needle based procedures.
If you compare this to say Quantum Surgical - and Epione - it's a different approach to do a similar function. You can't do everything a large system can do today. But others like OBVIUS Robotics, Inc. are also going down this route. It's a way of using parts of the robots in clever ways for specialist applications.
One of the best versions of using robotics in a hand held format (I've seen in the last weeks) is THINK Surgical and their T-Mini. Hand held orthopaedics robot. Worth looking at the video on their site, and see how this is a "lighter" touch to say a Mako - but with the potential to offer similar results - just - well - hand held.
In these systems you don't "get everything." But their philosophy is "You don't need everything."
These super specialist mini format robots won't replace all the large form factors - but we will see increasing numbers that will fit work flow - site of care and bring enough benefits through robotics to be major upgrades at affordable prices in healthcare. Plus they start to bring in that all important data and digital supportive workflow.
Think about Mainframes - to laptops - to iPhones...
Watch this space.
#healthrobotics #minrobots #digitalhealth | 11 comments on LinkedIn
🏆 Toumai® Wins the Ground-Breaking Technology Award! 🏆
We are thrilled to announce that the Toumai® Surgical Robot, developed by MicroPort® MedBot™, has been awarded the Ground-Breaking Technology Award at the Surgical Robotics Industry Awards 2025 — a prestigious recognition of our commitment to reshaping the future of surgery.
This award celebrates more than just an innovative device — it marks a bold leap forward in healthcare, where precision, intelligence, and global connectivity converge. Toumai®’s pioneering role in ultra-long-distance telesurgery has demonstrated its ability to transcend geographic boundaries and deliver expert surgical care across continents in real time.
From the world’s first FDA-IDE approved intercontinental robotic surgery trial, to a growing number of milestone procedures across Asia, Africa, and the Middle East, Toumai® has become more than just a surgical robot — it stands as a symbol of global collaboration, technological excellence, and equitable care.
We extend our sincere gratitude to our clinical partners, R&D teams, and everyone who shares our vision: to empower surgeons and connect patients with life-changing care — anywhere in the world.
🙏 A big THANK YOU to everyone who voted for and supported Toumai®!
🔗 Stay tuned as we continue pushing the boundaries of digital surgery and bringing cutting-edge innovation to operating rooms across the globe.
Telesurgery has emerged as a transformative force in modern medicine, with the potential to revolutionize surgical care, expand access in underserved areas, and create new opportunities in surgical training.
But is it truly safe and effective?
A groundbreaking multicenter study—led by Marcio Covas Moschovas MD, Ph.D, FACS, in collaboration with some of China’s leading surgical experts—has confirmed the safety and feasibility of performing cross-specialty telesurgical procedures using the next-generation Toumai® surgical robot.
✅ Smooth execution across multiple surgical specialties ✅ Stable performance over long distances ✅ Minimal latency and zero conversions ✅ A step forward for global surgical collaboration
📌 Toumai® is also officially approved by China’s National Medical Products Administration (NMPA) for commercial clinical use in telesurgery—marking a major milestone for China’s surgical robotics innovation and global readiness.
Advancing Healthcare_ The Role of Robotics and Artificial Intelligence in Medical Technology by Peter Rentrop MD.pdf - Download as a PDF or view online for free...
byJosh SandbergMay 15, 2025 FREMONT, Calif., May 15, 2025 /PRNewswire/ — THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announces that its TMINI® Miniature Robotic System has been used in its 1,000th total knee (TKA) procedure. The 1,000th case was recently completed by Dr. Adolph V. Lombardi Jr., of Joint Implant Surgeons, Inc. This new milestone comes quickly following the 500th case milestone as adoption of the TMINI System has accelerated across the country driven by THINK’s commercial partnerships with industry-leader Zimmer Biomet as well as other implant companies. “I perform the vast majority of my total knee replacement procedures in an Ambulatory Surgery Center, where space is at an ultimate premium,” said Dr. Lombardi. “With the version of the TMINI Miniature Robotic System exclusively available from Zimmer Biomet, I can use my implant of choice, Persona® Knee to deliver a personalized solution for my patients.” “The pace at which this second procedure milestone has been achieved is evidence that there is a strong demand for our miniature, handheld robotic technology in combination with our partners’ implants.” said Stuart Simpson, President, and Chief Executive Officer of THINK Surgical. “Approximately one third of cases performed so far were completed on the exclusive Zimmer Biomet TMINI Platform using the Persona Knee.” The TMINI Miniature Robotic System is commercially available throughout the United States. About THINK Surgical, Inc. THINK Surgical, Inc., is a privately held U.S.-based technology innovator that develops and markets orthopedic robots. THINK Surgical robots are open platforms providing support for implant brands from multiple manufacturers, enabling the choice of implant to be driven by the surgeon. THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent technology. Please refer to the instructions for use for the TMINI Miniature Robotic System for a complete list of indications, contraindications, warnings, and precautions. For additional product information, please visit www.thinksurgical.com. THINK Surgical, TMINI and TMINI PRO are trademarks of THINK Surgical, Inc. Zimmer Biomet, Persona and The Personalized Knee are trademarks of Zimmer, Inc. Media Contact: THINK Surgical Inc.Nick Margreenmargree@thinksurgical.com SOURCE THINK Surgical, Inc. milestoneMiniatureroboticsystemTHINK SurgicalTMINI®total knee arthroplasty byJosh Sandberg Published May 15, 2025 Keep Up to Date with the Most Important News Read more Recon Weight Still Top Risk Factor for Knee Arthritis, Pain byJosh SandbergJanuary 5, 2015 Extremities Recon Spine How Doctors Think About New Technologies byJosh SandbergJanuary 5, 2015 Biologics Recon Spine Scientist look for nanostructures that allow compatibility between metal and human bone tissues byJosh SandbergJanuary 5, 2015 Recon An alternative for pain control after knee replacement surgery byJosh SandbergJanuary 5, 2015 Extremities Recon Crash victim given donor leg bones in landmark operation byJosh SandbergJanuary 5, 2015 Neuro Recon Spine Electronic Medical Record (EMR) Benefits Outweigh Privacy Invasion Risk for Chronically Ill byJosh SandbergJanuary 6, 2015
Operative Neurosurgery 28:608–616, 2025 The study evaluates robotic resection of spinal nerve sheath tumors, demonstrating improved gross total resection rates and reduced hospital stays compared to open surgery.
Have you ever tried to tie your shoe laces with one arm?
There are today over 30 spine surgical robots that are commercial or in development, and this one is coming out of Switzerland.
Last week LEM Surgical AG - a robotic startup founded in 2021 and named after a science fiction writer - announced FDA clearance for the 𝗗𝘆𝗻𝗮𝗺𝗶𝘀 𝗥𝗼𝗯𝗼𝘁𝗶𝗰 𝗦𝘆𝘀𝘁𝗲𝗺.
The team has been developing this hard-tissue surgical robot that is not like most solutions available today that feature 1 arm holding 1 tool for pedicle screw placement.
Dynamis is the first-of-its-kind multi-arm system designed to help perform various procedures, starting with spine surgery.
The goal is to provide a bilateral, full body coverage, instrument agnostic robotic platform that will be capable of assisting in all procedural steps.
The North Star being 𝘀𝘂𝗽𝗲𝗿𝘃𝗶𝘀𝗲𝗱 𝗮𝘂𝘁𝗼𝗻𝗼𝗺𝗼𝘂𝘀 𝘀𝘂𝗿𝗴𝗲𝗿𝘆.
Once the cart is rolled under the table, the 3 arms are deployed around the patient and the device uses more than 11 cameras to get a full understanding of what's happening outside and inside the patient.
The company plans a limited product launch in the US this year, and is currently raising a Series C round to support commercialization.
To understand the why behind LEM Surgical, take 10 minutes to listen to the CEO Yossi Bar speaking at LSI USA'25 Emerging Medtech Summit: https://lnkd.in/eH8TpM2W
From the operating room to the front desk, robotics are now being integrated into a variety of applications with the purpose of freeing up time and services for healthcare workers to do what they do best, patient care.
Curious about the Robotic-Assisted Surgery landscape?
Check this very detailed report updated by FSI in March.
It covers close to 250 robotics companies, ecosystem overview, market size, landscape by platform type, analysis of VC investments, and a snapshot on the Chinese market.
Quantum Surgical has been highlighted along with 5 other companies that initiated or announced indication expanding trials during 2024.
As robotic adoption expands beyond knee and hip replacements into spine, shoulder, and trauma surgeries, staying ahead of the curve has never been more crucial. Download IQVIA MedTech's whitepaper, "The Rise of Robotics in Orthopedics: Innovations and Future Directions" to hear from IQVIA MedTech...
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.